Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Non Operating Income (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Non Operating Income for 6 consecutive years, with $11967.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 18.5% to $11967.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $80594.0, a 122.32% increase, with the full-year FY2024 number at $17277.0, down 81.2% from a year prior.
  • Non Operating Income was $11967.0 for Q3 2025 at Ensysce Biosciences, down from $16998.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $3.0 million in Q2 2022 to a low of -$8.6 million in Q4 2021.
  • A 5-year average of -$300095.6 and a median of $11967.0 in 2025 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 2180.8% in 2024; the steepest drop was 23602.47% in 2024.
  • Ensysce Biosciences' Non Operating Income stood at -$8.6 million in 2021, then soared by 109.24% to $794523.0 in 2022, then tumbled by 143.88% to -$348676.0 in 2023, then soared by 108.52% to $29690.0 in 2024, then crashed by 59.69% to $11967.0 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Non Operating Income are $11967.0 (Q3 2025), $16998.0 (Q2 2025), and $21939.0 (Q1 2025).